{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T23:00:05Z","timestamp":1791932405355,"version":"4.3.4"},"reference-count":43,"publisher":"Informa UK Limited","issue":"24","license":[{"start":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T00:00:00Z","timestamp":1655164800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Oncol."],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.2217\/fon-2022-0439","type":"journal-article","created":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T09:10:11Z","timestamp":1655197811000},"page":"2627-2638","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":33,"title":["Phase I study of VSV-GP (BI 1831169) as monotherapy or combined with ezabenlimab in advanced and refractory solid tumors"],"prefix":"10.1080","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3651-8867","authenticated-orcid":false,"given":"Mercedes","family":"Porosnicu","sequence":"first","affiliation":[{"name":"Department of Internal Medicine,Section on Hematology & Oncology,Wake Forest School of Medicine,\rWinston-Salem,\rNC 27157,\rUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4170-9310","authenticated-orcid":false,"given":"Anne-Marie","family":"Quinson","sequence":"additional","affiliation":[{"name":"Boehringer Ingelheim Pharmaceuticals Inc.,\rRidgefield,\rCT 06877,\rUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Crossley","sequence":"additional","affiliation":[{"name":"Boehringer Ingelheim Ltd,\rBracknell,\rUK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Luecke","sequence":"additional","affiliation":[{"name":"Biostatistics + Data Science Corp.,Boehringer Ingelheim Pharma GmbH & Co. KG,\rBiberach,\rGermany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4557-7730","authenticated-orcid":false,"given":"Ulrich M","family":"Lauer","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine VIII,Medical Oncology & Pneumology,University Hospital T\u00fcbingen,\rGermany"},{"name":"German Cancer Research Center (DKFZ),member of the German Cancer Consortium (DKTK),\rT\u00fcbingen,\rGermany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,6,14]]},"reference":[{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines5010008"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13215452"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.2217\/imt-2019-0033"},{"key":"e_1_3_5_7_1","unstructured":"Daiichi-Sankyo . DELYTACT\u00aeoncolytic virus G47\u0394 approved in japan for treatment of patients with malignant glioma (2021). www.daiichisankyo.com\/media\/press_release\/detail\/index_4110.html"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1089\/humc.2017.015"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.046672-0"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2013.06.003"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1214441110"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1099\/jgv.0.000980"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-13-3306"},{"issue":"3","key":"e_1_3_5_14_1","first-page":"321","article-title":"Status spongiousus resulting from intracerebral infection of mice with temperature-sensitive mutants of vesicular stomatitis virus","volume":"57","author":"Dal Canto MC","year":"1976","unstructured":"Dal Canto MC , RabinowitzSG, JohnsonTC. Status spongiousus resulting from intracerebral infection of mice with temperature-sensitive mutants of vesicular stomatitis virus. Br. J. Exp. Pathol.57(3), 321\u2013330 (1976).","journal-title":"Br. J. Exp. Pathol."},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.79.21.13705-13713.2005"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1995.1252"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-65-2-391"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2006.10.026"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01788-09"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1535-6108(03)00241-1"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2004.08.039"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02040-09"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01911-06"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02511-10"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/mto.2016.21"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.3390\/v10030108"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-019-0574-7"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.3390\/v10020090"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd4663"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3239"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaa8172"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.08.027"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00168"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40169-018-0214-5"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aam7577"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-016-0121-5"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2015.156"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/rssc.12089"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/1759-7714.14390"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph12040142"},{"key":"e_1_3_5_41_1","unstructured":"NCI . Common Terminology Criteria for Adverse Events (CTCAE) version 5.0. Division of cancer treatment and diagnosis (Ed.). NCI (2017). https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/docs\/ctcae_v5_quick_reference_5x7.pdf"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2018.12.758"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.02985"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-18-0309"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.abb8925"}],"container-title":["Future Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/fon-2022-0439","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T06:43:40Z","timestamp":1719125020000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/fon-2022-0439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,14]]},"references-count":43,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["10.2217\/fon-2022-0439"],"URL":"https:\/\/doi.org\/10.2217\/fon-2022-0439","relation":{},"ISSN":["1479-6694","1744-8301"],"issn-type":[{"value":"1479-6694","type":"print"},{"value":"1744-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,14]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-04-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-31","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-14","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}